TabletsClinical Overview
Ambroxol, Guaifenesin, and Bromhexine Expectorant Formulations (with Levosalbutamol or Terbutaline Syrup) is a comprehensive wet cough and mucociliary clearance formula on the PMBI formulary. Ambroxol stimulates pulmonary surfactant secretion by type II pneumocytes and depolymerizes mucopolysaccharides; bromhexine fragments mucin fibers; guaifenesin increases the volume and hydration of respiratory secretions, reducing mucus adhesiveness; and levosalbutamol/terbutaline relaxes bronchial smooth muscle. Indicated for productive wet cough associated with acute bronchitis, COPD, bronchiectasis, asthma, and tracheobronchitis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 5 to 10 mL two to three times daily after meals with a glass of water. Drink ample warm water throughout the day to maximize fluidization of bronchial secretions.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, loose stools, dyspepsia, mild tremor, palpitations, dizziness. Rare/Severe: Severe skin reactions (erythema multiforme, Stevens-Johnson syndrome) and allergic reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Over-The-Counter expectorant syrup. Ensure adequate daily fluid intake. Take after meals to avoid nausea. Discontinue if skin rash occurs.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Paracetamol 325mg + Phenylephrine 10mg + Chlorpheniramine 2mg Tablets
Paracetamol (325mg/500mg), Phenylephrine (10mg), and Chlorpheniramine Maleate (2mg) Tablets is a triple-action cold, sinus, and flu combination. Paracetamol relieves headache, body aches, sore throat, and fever. Phenylephrine is an alpha-1 adrenergic agonist that constricts swollen nasal mucosal blood vessels, relieving nasal and sinus congestion. Chlorpheniramine is a first-generation H1-antihistamine that blocks histamine receptors, drying rhinorrhea and eliminating sneezing and watery eyes. Indicated for symptomatic relief of common cold, allergic rhinitis, sinusitis, and influenza symptoms.
Cetirizine Dihydrochloride 5mg + Phenylephrine Hydrochloride 10mg + Paracetamol 325mg Tablets
Cetirizine (5mg), Phenylephrine (10mg), and Paracetamol (325mg) Tablets is a cold and sinus formula combining an analgesic/antipyretic with a second-generation H1-antihistamine and a sympathomimetic nasal decongestant. Relieves pain, fever, nasal obstruction, sneezing, and ocular pruritus associated with upper respiratory tract infections and allergic rhinitis with minimal sedation compared to first-generation antihistamines.
Paracetamol 125mg + Phenylephrine Hydrochloride 5mg + Cetirizine Dihydrochloride 2mg Suspension
Cetirizine Hydrochloride Tablets (5mg, 10mg) and Syrup (5mg/5ml) is a second-generation piperazine H1-antihistamine and active carboxylated metabolite of hydroxyzine on the WHO Model List of Essential Medicines. It selectively antagonizes peripheral H1 receptors, blocking histamine-induced wheal, flare, capillary permeability, and sensory nerve activation, while also inhibiting late-phase cutaneous and bronchial eosinophil recruitment. Indicated for relief of symptoms associated with seasonal and perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria.
Terbutaline Sulphate 1.25mg + Bromhexine 4mg + Guaiphenesin 50mg + Menthol 2.5mg Syrup per 5ml
Ambroxol, Guaifenesin, and Bromhexine Expectorant Formulations (with Levosalbutamol or Terbutaline Syrup) is a comprehensive wet cough and mucociliary clearance formula on the PMBI formulary. Ambroxol stimulates pulmonary surfactant secretion by type II pneumocytes and depolymerizes mucopolysaccharides; bromhexine fragments mucin fibers; guaifenesin increases the volume and hydration of respiratory secretions, reducing mucus adhesiveness; and levosalbutamol/terbutaline relaxes bronchial smooth muscle. Indicated for productive wet cough associated with acute bronchitis, COPD, bronchiectasis, asthma, and tracheobronchitis.